Due to a system-wide technology update, we are experiencing extremely high call volume. We appreciate your patience with our operators during this time. Thank you for choosing Fox Chase Cancer Center.
Fox Chase Cancer Center Earns Accreditation From American Nurses Credentialing Center
PHILADELPHIA (February 4, 2020) – Fox Chase Cancer Center has announced that its Nurse Residency Program achieved Practice Transition Accreditation from the American Nurses Credentialing Center (ANCC). They were awarded Accreditation with Distinction, the highest recognition awarded.
“This accreditation validates our program for being evidence-based, current, and relative to nursing practice,” said Deborah Baldassarre, MSN, RN, OCN, NPD-BC, Nursing Residency Program Coordinator. “It was a great experience for all of us here, to look at our program, evaluate it, and make it better.”
The ANCC Practice Transition Accreditation Program® validates hospital residency or fellowship programs that transition registered nurses (RNs) and advanced practice registered nurses into new practice settings that meet rigorous, evidence-based standards for quality and excellence.
Nurses in accredited transition programs such as Fox Chase’s Nurse Residency Program experience curricula that promote the acquisition of knowledge, skills, and professional behaviors necessary to deliver safe, high-quality care.
Fox Chase’s Nurse Residency Program is the 134th program to earn accreditation from the ANCC. The accreditation will last until May 2023, at which point the program will need to apply for re-accreditation.
“A lot of work went into achieving this accreditation, a lot of which could not have happened without the entire Nurse Residency Advisory Committee, the nurse residents, and Anne Jadwin,” said Baldassarre. Anne Jadwin, MSN, RN, AOCN, NE-BC, is chief nursing officer and vice president of nursing at Fox Chase. “I am proud to be a member of such a committed and dedicated nursing team.”
Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.
For more information, call 888-369-2427